Histone acetylation and disease
- 1 May 2001
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 58 (5) , 728-736
- https://doi.org/10.1007/pl00000896
Abstract
Differential acetylation of histones and transcription factors plays an important regulatory role in developmental processes, proliferation and differentiation. Aberrant acetylation or deacetylation leads to such diverse disorders as leukemia, epithelial cancers, fragile X syndrome and Rubinstein-Taybi syndrome. The various groups of histone acetyltransferases (CBP/p300, GNAT, MYST, nuclear receptor coactivators and TAFII250) and histone deacetylases are surveyed with regard to their possible or known involvement in cancer progression and human developmental disorders. Current treatment strategies are discussed, which are still mostly limited to histone deacetylase inhibitors such as trichostatin A and butyrate.Keywords
This publication has 0 references indexed in Scilit: